Autori: Rageliene L
| Naslov | Results from a large multinational clinical trial (guardian (TM) 3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics (Article) |
| Autori | Kulkarni R Karim Abdul F Glamocanin S Janic Dragana M  Vdovin V Ozelo M Rageliene L Carboni E Laguna P Dobaczewski G Seremetis S Lindblom A Santagostino E
|
| Info | HAEMOPHILIA, (2013), vol. 19 br. 5, str. 698-705 |
| Projekat | Novo Nordisk A/S (Bagsvaerd, Denmark) |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeding episodes in paediatric patients with severe haemophilia A and below 12 years of age (Meeting Abstract) |
| Autori | Kulkarni R Karim Abdul F Glamocanin S Janic Dragana M Vdovin V Ozelo M Rageliene L Carboni E Laguna P Dobaczewski G Santagostino E
|
| Info | HAEMOPHILIA, (2012), vol. 18 br. 5, str. 829-829 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
